青草性交图片

楼主: lixingyu2020
744 0

求Innovative Strategies, Statistical Solutions and Simulations for Modern Clinic [推广有奖]

  • 0关注
  • 0粉丝

svip1

初中生

38%

(VIP/贵宾)一级

63%

威望
0
论坛币
3843 个
通用积分
0
学术水平
0 点
热心指数
0 点
信用等级
0 点
经验
259 点
帖子
7
精华
0
在线时间
13 小时
注册时间
2020-6-29
最后登录
2022-8-24

楼主
lixingyu2020 在职认证  发表于 2022-8-23 21:08:19 |只看作者 |倒序

+2 论坛币
k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群
赵安豆老师微信:zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

感谢您参与论坛问题回答

经管之家送您两个论坛币!

+2 论坛币
求:Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series) 1st Edition
by Mark Chang (Author), John Balser (Author), Jim Roach (Author), Robin Bliss (Author)


"This is truly an outstanding book. [It] brings together all of the latest research in clinical trials methodology and how it can be applied to drug development…. Chang et al provide applications to industry-supported trials. This will allow statisticians in the industry community to take these methods seriously." Jay Herson, Johns Hopkins University


The pharmaceutical industry's approach to drug discovery and development has rapidly transformed in the last decade from the more traditional Research and Development (R & D) approach to a more innovative approach in which strategies are employed to compress and optimize the clinical development plan and associated timelines. However, these strategies are generally being considered on an individual trial basis and not as part of a fully integrated overall development program. Such optimization at the trial level is somewhat near-sighted and does not ensure cost, time, or development efficiency of the overall program. This book seeks to address this imbalance by establishing a statistical framework for overall/global clinical development optimization and providing tactics and techniques to support such optimization, including clinical trial simulations.


  • Provides a statistical framework for achieve global optimization in each phase of the drug development process.

  • Describes specific techniques to support optimization including adaptive designs, precision medicine, survival-endpoints, dose finding and multiple testing.

  • Gives practical approaches to handling missing data in clinical trials using SAS.

  • Looks at key controversial issues from both a clinical and statistical perspective.

  • Presents a generous number of case studies from multiple therapeutic areas that help motivate and illustrate the statistical methods introduced in the book.

  • Puts great emphasis on software implementation of the statistical methods with multiple examples of software code (both SAS and R).

It is important for statisticians to possess a deep knowledge of the drug development process beyond statistical considerations. For these reasons, this book incorporates both statistical and "clinical/medical" perspectives.




二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

关键词:Simulations Statistical Innovative Simulation Strategies

您需要登录后才可以回帖 登录 | 我要注册

京B2-20170662号 论坛法律顾问:王进律师 知识产权保护声明   免责及隐私声明

GMT+8, 2022-8-27 23:34